Skip to main content
Premium Trial:

Request an Annual Quote

Thomas McNally, Howard Kelly, Bob Thian, Hinrich Kehler, Tony Hunter, Tony Pawson, Alexander Levitzki, and Patricia Goldsmith

Premium

Thomas McNally has become vice chairman of Whatman, assuming functions from Howard Kelly, who stepped down as CEO in November, the company said last week. McNally, already a non-executive director of Whatman, will retain his new position until a new CEO is appointed. Previously, he held various positions at Abbott Laboratories.

Also, Bob Thian, chairman of Whatman, will be responsible for the integration and management of Schleicher & Schuell, which Whatman acquired in November.

In addition, Hinrich Kehler, until recently chairman of Schleicher & Schuell, has been appointed as a non-executive director. He holds a PhD in physical chemistry.


Tony Hunter, Tony Pawson, and Alexander Levitzki have been jointly awarded the 2005 Wolf Prize in Medicine for their research in cancer development and treatment, the Wolf Foundation said last week. They will equally share the $100,000 prize, which will be presented to them in Jerusalem on May 22.

Hunter, a professor of biology at the Salk Institute, is recognized for discovering tyrosine protein kinases. He holds a PhD from the University of Cambridge, UK.

Pawson, a senior scientist at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital in Toronto and a professor at the University of Toronto, is cited for discovering protein domains essential for mediating protein-protein interactions in cell signaling. He holds a PhD in molecular biology from London University and a BA in biochemistry from Cambridge University.

Levitzki is recognized for developing tyrosine kinase inhibitors to treat cancer, paving the way for drugs such as Gleevec. He is is a professor of biochemistry at the Hebrew University of Jerusalem. Levitzki holds a PhD in biochemistry and biophysics from Hebrew University and the Weizmann Institute of Science.


Patricia Goldsmith has become senior vice president of business development, public affairs, and policy at the National Comprehensive Cancer Network, NCCN said this week. She used to be vice president for institutional development, public affairs, and marketing at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Fla., an NCCN member institution.

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.